News | ANAVEX

View all Alzheimer's Disease Anavex2-73 Events News Releases PDD PIPELINE Press Rett Syndrome

Ladenburg Thalmann 2017 Healthcare Conference Sept 26 3:30pm

September 20, 2017

Anavex®Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73

September 5, 2017

CNS Diseases Summit 2017 Sept 11-12

August 24, 2017

Anavex Reports Fiscal Third Quarter 2017 Financial Results

Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board

2017 Bio International Convention June 19-22

Anavex Life Sciences to Present at Jefferies 2017 Global Healthcare Conference

Jefferies 2017 Global Healthcare Conference June 6-9

Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome − Data Presented at Antiepileptic Drug Trials XIV 2017 Conference

Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome − Data Presented at Antiepileptic Drug Trials XIV 2017 Conference −

Anavex President & CEO Christopher U. Missling, PhD, to present preclinical data on ANAVEX 2-73™ at the Epilepsy Foundation’s Antiepileptic Drug Trials XIV Conference on May 19.

Anavex Reports Fiscal Second Quarter 2017 Financial Results